SunBio Inc.

About SunBio Inc.

SunBio is a biotech company developing biosimilars, biopharmaceuticals, and medical devices based on our proprietary technologies of pegylation.SunBio offers a variety of PEG product, or activated PEG derivatives, that are crucial ingredients in the art of PEGylation. The EMA-approved GMP manufacturing facility for manufacturing of PEG products is in operation.SunBio’s biosimilar product, PEG-filgrastim, has been marketed in EU (Pelgraz™) and Canada (Lapelga™) since 2018 and in India (NeuPEG™) since 2008.

Read more Show less
Certifications
  • FDA
    FDA
  • GMP
    GMP
  • ISO
    ISO
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • KR
  • 2024
    On CPHI since
  • 3
    Certificates
  • 25 - 49
    Employees
Company types
Biopharmaceutical company
Pharmaceutical company
Primary activities
API Producer
Biopharmaceutical
View company profile
Contact info
  • +82 1049510042
  • Website
  • 95 Sanbon-ro, Gunpo-si, Gyeonggi-do, 15849, Gunpo City, Gyen, Korea, Republic Of
Show contact info Hide contact info
Meet us at

CPHI North America 2024

Pennsylvania Convention Center, Philadelphia
07 May 2024 - 09 May 2024
View Exhibitor Profile

CPHI Milan 2024

Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024
View Exhibitor Profile

SunBio Inc. Resources (1)

  • PEG-SHOP Catalog

    Brochure PEG-SHOP Catalog

    SunBio PEG-SHOP offers a variety of PEG derivatives including, methoxy PEG derivatives, PEG-bifunctional derivatives, 4-arm PEG derivatives having a pentaerythritol core, and 6-arm PEG derivatives having a sorbitol core.